https://www.selleckchem.com/products/bi-1347.html
The mRNA level of MGMT was significantly associated with those of ESR1, GATA3 and FOXA1 in ER-positive breast tumor. Down-regulation of MGMT expression enhanced the proliferative and invasive capacities of breast cancer cells through PTEN/AKT pathway. Conclusions MGMT is a favorable biomarker with proliferation suppressive potential in ER-positive breast cancer. Future study on targeted modulation of MGMT in the treatment of breast cancer is warranted.Aim To study the value and efficiency of CEA/CA72-4 immunohistochemistry in detecting
Curtir
Comentario
Compartilhar
